Join to View Full Profile
6301 Almeda RdApt 841Houston, TX 77021
Phone+1 832-374-0634
Dr. Schvartsman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Paulista School of MedicineClass of 2012
Publications & Presentations
PubMed
- 1 citationsSafety and efficacy of topical testosterone in breast cancer patients receiving ovarian suppression and aromatase inhibitor therapy.Patrícia Taranto, Diogo de Brito Sales, Fernando Cotait Maluf, Rafael Aliosha Kaliks Guendelmann, Luciano de Melo Pompei
Breast Cancer Research. 2024-09-16 - 23 citationsAssociation between weight gain during adjuvant chemotherapy for early-stage breast cancer and survival outcomes.Gustavo Schvartsman, Angelica M. Gutierrez-Barrera, Juhee Song, Naoto T. Ueno, Susan K. Peterson
Cancer Medicine. 2017-10-10 - 174 citationsResponse rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer.Gustavo Schvartsman, S. Andrew Peng, Giorgios Bis, J. Jack Lee, Marcelo F. Benveniste
Lung Cancer. 2017-10-01
Lectures
- Outcomes of metastatic melanoma (MM) patients (pts) after discontinuation of anti-Programmed-Death 1 (PD1) therapy without disease progression.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- A phase II study of study of bevacizumab (BEV) in combination with atezolizumab (ATEZO) in pts (pts) with untreated melanoma brain metastases (BEAT-MBM).2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
